Good to see more European centres opened for the trial. The rate of stem cell transplants in Italy and France are 9.4 and 8.6 per 100,000 people, compared to approximately 6.8 per 100,000 people in the USA [2]. More transplants unfortunately = More GvHD and the opportunity for patients to be treated with Cymerus iPSC derived MSCs worth hundreds of thousands of dollars (if you believe Silviu Itescu).
[1]: https://ec.europa.eu/eurostat/en/web/products-eurostat-news/-/edn-20201010-1
[2]: https://bloodstemcell.hrsa.gov/data/donation-and-transplantation-statistics
- Forums
- ASX - By Stock
- CYP
- GVHD Clinical trial record updated
CYP
cynata therapeutics limited
Add to My Watchlist
2.86%
!
17.0¢

GVHD Clinical trial record updated, page-4
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
17.0¢ |
Change
-0.005(2.86%) |
Mkt cap ! $38.41M |
Open | High | Low | Value | Volume |
18.0¢ | 18.0¢ | 16.5¢ | $41.91K | 247.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 8275 | 17.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
17.5¢ | 3700 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 8275 | 0.170 |
2 | 43375 | 0.165 |
3 | 92975 | 0.160 |
3 | 181290 | 0.155 |
6 | 323045 | 0.150 |
Price($) | Vol. | No. |
---|---|---|
0.175 | 3700 | 1 |
0.180 | 174734 | 2 |
0.185 | 25916 | 1 |
0.190 | 30000 | 1 |
0.195 | 9659 | 3 |
Last trade - 16.10pm 30/07/2025 (20 minute delay) ? |
Featured News
CYP (ASX) Chart |